Menu
Recruiting NCT06833450

Reliability of IUS in Crohn's Disease

No phase Interventional Crohn Disease (CD)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Transabdominal intestinal ultrasound.
Who it may be relevant to
Registry conditions: Crohn Disease (CD). Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

Transabdominal intestinal ultrasound (IUS) is gaining acceptance as a point-of-care test to objectively assess disease activity in Crohn's disease (CD). In order to incorporate individual parameters in a future definition of transmural healing, and for the consistent application of IUS as a modality to assess treatment outcomes and establish therapeutic targets to ensure comparability between future studies, the inter-observer agreement should be determined for all relevant parameters.

Interventions

  • Other Transabdominal intestinal ultrasound
    Transabdominal intestinal ultrasound

Primary outcome measures

  • Number of different IUS parameters between two operators [Time frame: 1 year]

Eligibility criteria

Inclusion criteria

  • Crohn's disease evolving for at least 1 months
  • Patient older than 18 years
  • Patient covered by French national health insurance
  • Written informed consent

Exclusion criteria

  • Pregnant women or breastfeeding
  • Minor
  • Patient deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Non-randomized
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

France · 1 center
  • CHU d'Amiens — Amiens

Identifiers

NCT: NCT06833450 · PI2022_843_0006

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗